- Tytuł :
- Update on HER2 expression in breast cancer
- Autorzy :
- Źródło :
- In Diagnostic Histopathology March 2022 28(3):170-175
-
Czasopismo naukowe
Wyszukujesz frazę ""ERBB2 mutation"" wg kryterium: Temat
- Tytuł :
-
Case Report: PTEN
Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma - Autorzy :
- Temat :
-
ErbB2 mutation
afatinib
adenocarcinoma cell lung carcinoma
PTENmutation
immunotherapy
Therapeutics. Pharmacology
RM1-950 - Źródło :
- Frontiers in Pharmacology, Vol 13 (2022)
- Opis pliku :
- electronic resource
- Relacje :
- https://www.frontiersin.org/articles/10.3389/fphar.2022.714408/full; https://doaj.org/toc/1663-9812
- Dostęp URL :
- https://doaj.org/article/4aabca8cc79f491589acb37fa0e51328
-
Czasopismo naukowe
- Tytuł :
- The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
- Autorzy :
- Źródło :
- In Clinical Lung Cancer January 2022 23(1):52-59
-
Czasopismo naukowe
- Tytuł :
-
Successful treatment of pyrotinib for bone marrow metastasis induced pancytopenia in a patient with non‐small‐cell lung cancer and
ERBB2 mutation - Autorzy :
- Temat :
-
Bone marrow metastasis
ERBB2 mutation
NSCLC
pyrotinib
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Źródło :
- Thoracic Cancer, Vol 11, Iss 7, Pp 2051-2055 (2020)
- Opis pliku :
- electronic resource
- Relacje :
- https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714
- Dostęp URL :
- https://doaj.org/article/32b10ca683664d5b86e587360b5d4a40
-
Czasopismo naukowe
- Tytuł :
-
Mutational landscape and characteristics of
ERBB2 in non‐small cell lung cancer - Autorzy :
- Temat :
-
Co‐
mutation ERBB2 mutation
non‐small cell lung cancer
oncogenic function
prognosis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Źródło :
- Thoracic Cancer, Vol 11, Iss 6, Pp 1512-1521 (2020)
- Opis pliku :
- electronic resource
- Relacje :
- https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714
- Dostęp URL :
- https://doaj.org/article/9940ece6534e48e583a31a88127b36c4
-
Czasopismo naukowe
- Tytuł :
-
Activity of Afatinib in Heavily Pretreated Patients With
ERBB2 Mutation –Positive Advanced NSCLC: Findings From a Global Named Patient Use Program - Autorzy :
- Źródło :
- In Journal of Thoracic Oncology December 2018 13(12):1897-1905
-
Czasopismo naukowe
- Tytuł :
-
ERBB2 mutation : A promising target in non-squamous cervical cancer - Autorzy :
- Źródło :
- In Gynecologic Oncology February 2018 148(2):311-316
-
Czasopismo naukowe
- Tytuł :
-
Alterations in
ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma - Autorzy :
- Temat :
-
Small bowel adenocarcinoma
BRCAmutation
PARP-inhibitionERBB2 mutation
Microsatellite-instability
Diseases of the digestive system. Gastroenterology
RC799-869 - Źródło :
- BMC Gastroenterology, Vol 19, Iss 1, Pp 1-6 (2019)
- Opis pliku :
- electronic resource
- Relacje :
- http://link.springer.com/article/10.1186/s12876-019-0942-z; https://doaj.org/toc/1471-230X
- Dostęp URL :
- https://doaj.org/article/6877420e7dd24c4ca9eb6d41ff1a1165
-
Czasopismo naukowe
- Tytuł :
-
Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in
ERBB2 -Mutated Breast Cancer: In Silico Analysis - Autorzy :
- Temat :
-
Cancer Research
Oncology
General Medicine
Pathology and Forensic Medicine
Society Journal Archive
Original Research
Breast cancerErbB2 mutation
tumor mutational burden
tumour-infiltrating lymphocytes
Bioinformactics analysis
skin and connective tissue diseases - Źródło :
-
Crossref
Pathology and Oncology Research - Dostępność :
-
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48dfabd606a5b609106e268a999c7ce5
https://www.por-journal.com/articles/10.3389/pore.2021.633243/full
- Tytuł :
-
Alterations in
ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma - Autorzy :
- Źródło :
- BMC Gastroenterology. 19(1)
-
Czasopismo naukowe
- Tytuł :
-
Gallbladder cancer harboring
ERBB2 mutation on the primary and metastatic site: A case report - Autorzy :
- Temat :
-
Gall bladder cancer
Bile duct cancerERBB2 mutation
Precision medicineMutation -driven targeted treatment
Case report
Gastroenterology
Oncology
Medicine
business.industry
business
Cancer research
medicine.diseaseMutation
medicine.disease_cause
Gallbladder cancer - Źródło :
-
World Journal of Gastrointestinal Oncology
Crossref - Dostępność :
-
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4631f713373f3732e4c9db20534509dc
http://hdl.handle.net/2297/00062707
- Informacja :
- Dostęp do tej pozycji wymaga zalogowania się.
-
Czasopismo naukowe
- Informacja :
- Dostęp do tej pozycji wymaga zalogowania się.
-
Czasopismo naukowe
- Tytuł :
-
Alterations in
ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma - Autorzy :
- Temat :
-
Gastroenterology
General Medicine
Medicine
business.industry
business
MSH2
KRAS
medicine.disease_cause
Neuroblastoma RAS viral oncogene homolog
Cancer research
MLH1
MSH6
Microsatellite instability
medicine.disease
PMS2
HRAS
Small bowel adenocarcinoma
BRCAmutation
PARP-inhibitionERBB2 mutation
Microsatellite-instability
lcsh:Diseases of the digestive system. Gastroenterology
lcsh:RC799-869
Research Article
neoplasms
digestive system diseases - Źródło :
-
Crossref
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-6 (2019)
BMC Gastroenterology - Dostępność :
- https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c521dc8abd89bb0e305e1b802ec9af5
- Tytuł :
-
ERBB2 MUTATION : A PROMISING TARGET IN NON-SQUAMOUS CERVICAL CANCER - Autorzy :
- Temat :
-
cervical cancer
erbb2 mutation
pik3camutation
krasmutation
targeted therapy - Źródło :
- Crossref
- Dostępność :
- https://explore.openaire.eu/search/publication?articleId=doi_________::933a3a82097c191a26f9c7cdab253855
- Tytuł :
-
Activity of Afatinib in Heavily Pretreated Patients With
ERBB2 Mutation -Positive Advanced NSCLC: Findings From a Global Named Patient Use Program - Autorzy :
- Temat :
-
Adult
Afatinib/therapeutic use
Aged
Aged, 80 and over
Antineoplastic Agents/therapeutic use
Carcinoma, Non-Small-Cell Lung/drug therapy
Carcinoma, Non-Small-Cell Lung/genetics
Carcinoma, Non-Small-Cell Lung/pathology
Female
Follow-Up Studies
Humans
Lung Neoplasms/drug therapy
Lung Neoplasms/genetics
Lung Neoplasms/pathology
Male
Middle AgedMutation
Prognosis
Receptor, ErbB-2/genetics
Retrospective Studies
Salvage Therapy
AfatinibERBB2 mutation
NSCLC
Clinic for Oncology and Hematology
610 Medicine & health
Pulmonary and Respiratory Medicine
Oncology
medicine.drug
medicine
business.industry
business
Discontinuation
Erlotinib
medicine.medical_specialty
Gefitinib
Exon
Internal medicine
medicine.disease_cause
Receptor tyrosine kinase
biology.protein
biology
Disease control
neoplasms - Źródło :
-
Journal of thoracic oncology, vol. 13, no. 12, pp. 1897-1905
Peters, Solange; Curioni-Fontecedro, Alessandra; Nechushtan, Hovav; Shih, Jin-Yuan; Liao, Wei-Yu; Gautschi, Oliver; Spataro, Vito; Unk, Mojca; Chih-Hsin Yang, James; Lorence, Robert M; Carrière, Philippe; Cseh, Agnieszka; Chang, Gee-Chen (2018). Activity of Afatinib in Heavily Pretreated Patients WithERBB2 Mutation -Positive Advanced NSCLC: Findings From a Global Named Patient Use Program. Journal of Thoracic Oncology, 13(12):1897-1905.
Crossref - Opis pliku :
- application/pdf
- Dostępność :
-
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a46737805b345849c87401cd2e9620
https://serval.unil.ch/notice/serval:BIB_29FF3A29D783
Wyświetlanie 1-20 z 58